Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Acceleron Pharma, Inc., A Wholly-owned Subsidiary Of Merck & Co., Inc., Rahway, Nj Usa

Clinical trials sponsored by Acceleron Pharma, Inc., A Wholly-owned Subsidiary Of Merck & Co., Inc., Rahway, Nj Usa, explained in plain language.

Completed 2 Terminated 1

New drug sotatercept tested to slow PAH progression

Disease control Terminated

This Phase 3 trial tested the drug sotatercept in 321 people newly diagnosed with intermediate- or high-risk pulmonary arterial hypertension (PAH). Participants received either sotatercept or a placebo added to their usual PAH therapy. The goal was to see if sotatercept could del…

Phase: PHASE3 • Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA • Aim: Disease control

Last updated Jun 27, 2026 13:04 UTC